dextroamphetamine 18 MG in 9 HR Transdermal System

RxCUI
2624712
RxNorm name
dextroamphetamine 18 MG in 9 HR Transdermal System
Display name
dextroamphetamine 18 MG in 9 HR Transdermal System
Full name
dextroamphetamine 18 MG in 9 HR Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLC0862f02a-72a8-41cc-8845-57cf4974bb6f2025-12-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2624712

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0862f02a-72a8-41cc-8845-57cf4974bb6fdextroamphetamine 18 MG in 9 HR Transdermal SystemPSN17These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223
0862f02a-72a8-41cc-8845-57cf4974bb6f9 HR dextroamphetamine 2 MG/HR Transdermal SystemSCD17These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223
0862f02a-72a8-41cc-8845-57cf4974bb6fdextroamphetamine 18 MG per 9 HR Transdermal SystemSY17These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223